SECsense Logo

Kiniksa Pharmaceuticals 8-K Report: Key Updates for Investors on Feb 21, 2025

$KNSA
Form 8-K
Filed on: 2025-02-25
Source
Kiniksa Pharmaceuticals 8-K Report: Key Updates for Investors on Feb 21, 2025

Here are the key pieces of information extracted from the provided section of the financial report for Kiniksa Pharmaceuticals International, plc:

  1. Company Identification:
  • Name: Kiniksa Pharmaceuticals International, plc
  • CIK: 0001730430
  • Trading Symbol: KNSA
  • Exchange: NASDAQ
  • Tax ID: 98-1795578
  • Address: 23 Old Bond Street, Floor 3, London W1S 4PZ, GB
  • Phone Number: 781-431-9100
  1. Filing Details:
  • Form Type: 8-K (current report)
  • Filing Date: February 21, 2025
  1. Financial Metrics:
  • Reporting Date: February 21, 2025
  • Nominal Value of Shares: $0.000273235
  • Class of Shares: Class A Ordinary Shares
  1. Units and Measures:
  • Currency: United States Dollar (USD)
  • Measurement Units: USD, Shares, and a combined measure of USD per Share
  1. Contextual Information:
  • This report appears to be a current report (8-K), which is typically used to announce major events that shareholders should know about.

The report does not provide specific financial results or operational details, but it indicates a recent filing by Kiniksa Pharmaceuticals that may pertain to significant corporate developments.